174 related articles for article (PubMed ID: 30552476)
1. Wavelet-based reconstruction of dynamic susceptibility MR-perfusion: a new method to visualize hypervascular brain tumors.
Huber T; Rotkopf L; Wiestler B; Kunz WG; Bette S; Gempt J; Preibisch C; Ricke J; Zimmer C; Kirschke JS; Sommer WH; Thierfelder KM
Eur Radiol; 2019 May; 29(5):2669-2676. PubMed ID: 30552476
[TBL] [Abstract][Full Text] [Related]
2. The wavelet power spectrum of perfusion weighted MRI correlates with tumor vascularity in biopsy-proven glioblastoma samples.
Rotkopf LT; Wiestler B; Preibisch C; Liesche-Starnecker F; Pyka T; Nörenberg D; Bette S; Gempt J; Thierfelder KM; Zimmer C; Huber T
PLoS One; 2020; 15(1):e0228030. PubMed ID: 31971966
[TBL] [Abstract][Full Text] [Related]
3. Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.
Leu K; Enzmann DR; Woodworth DC; Harris RJ; Tran AN; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
Cancer Imaging; 2014 Nov; 14(1):31. PubMed ID: 25608485
[TBL] [Abstract][Full Text] [Related]
4. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.
Lee B; Park JE; Bjørnerud A; Kim JH; Lee JY; Kim HS
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1415-1422. PubMed ID: 30026384
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Cerebral Blood Volume Image Synthesis from Standard MRI Using Image-to-Image Translation for Brain Tumors.
Wang B; Pan Y; Xu S; Zhang Y; Ming Y; Chen L; Liu X; Wang C; Liu Y; Xia Y
Radiology; 2023 Aug; 308(2):e222471. PubMed ID: 37581504
[TBL] [Abstract][Full Text] [Related]
6. Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.
Ken S; Deviers A; Filleron T; Catalaa I; Lotterie JA; Khalifa J; Lubrano V; Berry I; Péran P; Celsis P; Moyal EC; Laprie A
J Neurooncol; 2015 Sep; 124(3):465-73. PubMed ID: 26189058
[TBL] [Abstract][Full Text] [Related]
7. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
[TBL] [Abstract][Full Text] [Related]
8. Wavelet-based calculation of cerebral angiographic data from time-resolved CT perfusion acquisitions.
Havla L; Thierfelder KM; Beyer SE; Sommer WH; Dietrich O
Eur Radiol; 2015 Aug; 25(8):2354-61. PubMed ID: 25716940
[TBL] [Abstract][Full Text] [Related]
9. Differences in dynamic susceptibility contrast MR perfusion maps generated by different methods implemented in commercial software.
Orsingher L; Piccinini S; Crisi G
J Comput Assist Tomogr; 2014; 38(5):647-54. PubMed ID: 24879459
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of combined visualization of MR diffusion and perfusion maps in glioblastoma.
Deike K; Wiestler B; Graf M; Reimer C; Floca RO; Bäumer P; Kickingereder P; Heiland S; Schlemmer HP; Wick W; Bendszus M; Radbruch A
J Neurooncol; 2016 Feb; 126(3):463-72. PubMed ID: 26518541
[TBL] [Abstract][Full Text] [Related]
13. Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.
Varallyay CG; Nesbit E; Horvath A; Varallyay P; Fu R; Gahramanov S; Muldoon LL; Li X; Rooney WD; Neuwelt EA
J Magn Reson Imaging; 2018 Aug; 48(2):441-448. PubMed ID: 29314418
[TBL] [Abstract][Full Text] [Related]
14. Transit time corrected arterial spin labeling technique aids to overcome delayed transit time effect.
Yun TJ; Sohn CH; Yoo RE; Kang KM; Choi SH; Kim JH; Park SW; Hwang M; Lebel RM
Neuroradiology; 2018 Mar; 60(3):255-265. PubMed ID: 29288284
[TBL] [Abstract][Full Text] [Related]
15. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
16. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
Hojjati M; Badve C; Garg V; Tatsuoka C; Rogers L; Sloan A; Faulhaber P; Ros PR; Wolansky LJ
J Neuroimaging; 2018 Jan; 28(1):118-125. PubMed ID: 28718993
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
18. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
[TBL] [Abstract][Full Text] [Related]
19. Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.
Lee J; Jain R; Khalil K; Griffith B; Bosca R; Rao G; Rao A
AJNR Am J Neuroradiol; 2016 Jan; 37(1):37-43. PubMed ID: 26471746
[TBL] [Abstract][Full Text] [Related]
20. Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements.
Cha S; Lu S; Johnson G; Knopp EA
J Magn Reson Imaging; 2000 Feb; 11(2):114-9. PubMed ID: 10713942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
